Hemolytics is developing a patented chemical amplification method enabling ultrasensitive detection of malaria using inexpensive reagents. It may be used as a point of care diagnostic test kit with a sensitivity 10-fold superior to that of the most sophisticated currently available malaria rapid diagnostic tests (MRDT). This product, named AMPLARIA, fills a niche in the malaria market as it enables efficient reactive case detection (RCD).